Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions: SARS-CoV 2; ARDS Intervention: Drug: Dornase Alfa Inhalation Solution Sponsor: University of Missouri-Columbia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials